Companies researching Keytruda (pembrolizumab)
Keytruda (pembrolizumab) is a humanized monoclonal antibody used in cancer immunotherapy to treat melanoma, lung, head‑and‑neck, Hodgkin lymphoma, stomach, cervical and certain breast cancers, administered via intravenous infusion.
35
companies
List of companies that research Keytruda (pembrolizumab)
| Company | Country | Industry | Employees | Revenue | Technologies |
|---|---|---|---|---|---|
United States | Biotechnology Research | 325 | Keytruda (pembrolizumab) | ||
United States | Biotechnology Research | 249 | Keytruda (pembrolizumab) | ||
Canada | Financial Services | 1.3k | Keytruda (pembrolizumab) | ||
United States | Pharmaceutical Manufacturing | 3.4k | $15M | Keytruda (pembrolizumab) | |
Italy | Hospitals and Health Care | 5.9k | Keytruda (pembrolizumab) | ||
United States | Business Consulting and Services | 97 | $18M | Keytruda (pembrolizumab) | |
United States | Hospitals and Health Care | 21k | $5.5B | Keytruda (pembrolizumab) | |
Denmark | Government Administration | 10k | Keytruda (pembrolizumab) | ||
Netherlands | Hospitals and Health Care | 10k | $3.8M | Keytruda (pembrolizumab) | |
United States | Hospitals and Health Care | 1k | $4.2M | Keytruda (pembrolizumab) |
Showing top companies out of 35 that research Keytruda (pembrolizumab). Get the full list on TheirStack.
Frequently asked questions








